High intensity focused ultrasound technology, its scope and applications in therapy and drug delivery

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 17, Issue 1, 2014, Pages 136-153

  Phenix, Christopher P ^a,b,c   Togtema, Melissa ^a,b   Pichardo, Samuel ^b,d   Zehbe, Ingeborg ^a,b,c   Curiel, Laura ^a,b  

^a Thunder Bay Regional Research Institute   (Canada)

^b LAKEHEAD UNIVERSITY   (Canada)

^c NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUNEX; DOXORUBICIN; ECHOVIST; PERFLUTREN; SHU 508; SONOVUE;

APHERESIS; BIOLOGICAL ACTIVITY; BLOOD BRAIN BARRIER; CELL MEMBRANE; CELL PERMEABILIZATION; CHEMICAL PROCEDURES; CLINICAL EFFECTIVENESS; DEVICE SAFETY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ECHOCARDIOGRAPHY; HEMATOLOGICAL PROCEDURE; HIGH INTENSITY FOCUSED ULTRASOUND; HIGH TEMPERATURE PROCEDURES; HUMAN; HYPERTHERMIC THERAPY; MICROBUBBLE; NON INVASIVE PROCEDURE; NONHUMAN; REVIEW; SONOPORATION; SONOTHROMBOLYSIS; THERAPY EFFECT; ULTRASOUND SCANNER; ANIMAL; ECHOGRAPHY; MECHANICAL THROMBECTOMY; PROCEDURES; ULTRASOUND;

ANIMALS; BLOOD-BRAIN BARRIER; DRUG DELIVERY SYSTEMS; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; MECHANICAL THROMBOLYSIS; ULTRASONICS;

EID: 84898468706     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3zp5f     Document Type: Review

References (186)

1. Curie P, Curie J. Développement, par pression, de électricité polaire dans les cristaux hémièdres à faces inclinées. Académie des sciences (France) Comptes rendus hebdomadaires des séances de l'Académie des sciences 1880:294-295.
2. Chilowski C, Langevin P, inventors. Production of submarine signals and the location of submarine objects 1923.
3. Suslick KS. Sonochemistry. Science 1990;247 (4949):1439-1445.
4. Suslick KS, Flannigan DJ. Inside a collapsing bubble: sonoluminescence and the conditions during cavitation. Annu Rev Phys Chem 2008; 59:659-683.
5. Flannigan DJ, Suslick KS. Plasma formation and temperature measurement during single-bubble cavitation. Nature 2005 Mar 3;434(7029):52-55.
6. Skauen DM. Some pharmaceutical applications of ultrasonics. J Pharm Sci 1967 Nov;56(11):1373-1385.
7. Shirsath SR, Sonawane SH, Gogate PR. Intensification of extraction of natural products using ultrasonic irradiations:A review of current status. Chemical Engineering and Processing: Process Intensification 2012/3;53(0):10-23.
8. Higgins DM, Skauen DM. Influence of power on quality of emulsions prepared by ultrasound. J Pharm Sci 1972 Oct;61(10):1567-1570.
9. Mason TJ. Ultrasound in synthetic organic chemistry. Chem Soc Rev 1997;26(6):443-451.
10. Shah RB, Zidan AS, Funck T, Tawakkul MA, Nguyenpho A, Khan MA. Quality by design: characterization of self-nano-emulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology. Int J Pharm 2007 Aug 16;341(1-2):189-194.
11. Xu H, Suslick KS. Sonochemical synthesis of highly fluorescent ag nanoclusters. ACS Nano 2010 Jun 22;4(6):3209-3214.
12. Dhas NA, Suslick KS. Sonochemical preparation of hollow nanospheres and hollow nanocrystals. J Am Chem Soc 2005 Mar 2;127(8):2368-2369.
13. Skrabalak SE, Suslick KS. Porous MoS2 synthesized by ultrasonic spray pyrolysis. J Am Chem Soc 2005 Jul 20;127(28):9990-9991.
14. Hill CR, Bamber JC. Methodology for clinical investigation. Physical Principles of Medical Ultrasonics, Second Edition 2004:255-302.
15. ter Haar G. Intervention and therapy. Ultrasound Med Biol 2000 May;26 Suppl 1:S51-4.
16. van den Bekerom MP, van der Windt DA, Ter Riet G, van der Heijden GJ, Bouter LM. Therapeutic ultrasound for acute ankle sprains. Cochrane Database Syst Rev 2011 Jun 15;(6):CD001250. doi(6):CD001250.
17. Huber M, Prantl L, Gehmert S. Successful treatment of nonunion in severe finger injury with low-intensity pulsed ultrasound (LIPUS): a case report. J Med Case Rep 2012 Jul 18;6(1):209-1947-6-209.
18. Deshpande N, Needles A, Willmann JK. Molecular ultrasound imaging: current status and future directions. Clin Radiol 2010;65(7):567-581.
19. Bohmer MR, Klibanov AL, Tiemann K, Hall CS, Gruell H, Steinbach OC. Ultrasound triggered image-guided drug delivery. Eur J Radiol 2009 May;70(2):242-253.
20. Hynynen K. Macromolecular delivery across the blood-brain barrier. Methods Mol Biol 2009; 480:175-185.
21. Harvey EN, Harvey EB, Loomis AL. Further observations on the effect of high frequency sound waves on living matter. Biol Bull 1928;55(6):459-469.
22. Lynn JG, Zwemer RL, Chick AJ, Miller AE. A New Method for the Generation and use of Focused Ultrasound in Experimental Biology. J Gen Physiol 1942 Nov 20;26(2):179-193.
23. The use of ultrasound in neurosurgery. Proceedings of the Third International Conference on Medical Electronics; 1960.
24. Goss SA, Frizzell LA, Dunn F. Ultrasonic absorption and attenuation in mammalian tissues. Ultrasound Med Biol 1979;5(2):181-186.
25. Lee CS, Frizzell LA. Exposure levels for ultrasonic cavitation in the mouse neonate. Ultrasound Med Biol 1988;14(8):735-742.
26. O'Brien WD, Jr. Ultrasound-biophysics mechanisms. Prog Biophys Mol Biol 2007 Jan-Apr;93(1-3):212-255.
27. O'Brien WD, Jr, Simpson DG, Ho MH, Miller RJ, Frizzell LA, Zachary JF. Superthreshold behavior and threshold estimation of ultrasound-induced lung hemorrhage in pigs: role of age dependency. IEEE Trans Ultrason Ferroelectr Freq Control 2003 Feb;50(2):153-169.
28. O'Brien WR, Ellis DS. Evaluation of the unscanned soft-tissue thermal index. IEEE Trans Ultrason Ferroelectr Freq Control 1999;46(6):1459-1476.
29. Zhou YF. High intensity focused ultrasound in clinical tumor ablation. World J Clin Oncol 2011 Jan 10;2(1):8-27.
30. Pennes HH. Analysis of tissue and arterial blood temperatures in the resting human forearm. 1948. J Appl Physiol 1998 Jul;85(1):5-34.
31. Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984 Jun;10(6):787-800.
32. Billard BE, Hynynen K, Roemer RB. Effects of physical parameters on high temperature ultrasound hyperthermia. Ultrasound Med Biol 1990;16 (4):409-420.
33. Daum DR, Smith NB, King R, Hynynen K. In vivo demonstration of noninvasive thermal surgery of the liver and kidney using an ultrasonic phased array. Ultrasound Med Biol 1999 Sep;25(7):1087-1098.
34. Damianou C, Hynynen K. The effect of various physical parameters on the size and shape of necrosed tissue volume during ultrasound surgery. J Acoust Soc Am 1994 Mar;95(3):1641-1649.
35. Pichardo S, Sin VW, Hynynen K. Multi-frequency characterization of the speed of sound and attenuation coefficient for longitudinal transmission of freshly excised human skulls. Phys Med Biol 2011 Jan 7;56(1):219-250.
36. Pichardo S, Hynynen K. Treatment of near-skull brain tissue with a focused device using shear- mode conversion: a numerical study. Phys Med Biol 52(24) 2007;52(24):7313-7332.
37. Burtnyk M, N'Djin WA, Kobelevskiy I, Bronskill M, Chopra R. 3D conformal MRI-controlled transurethral ultrasound prostate therapy: validation of numerical simulations and demonstration in tissue-mimicking gel phantoms. Phys Med Biol 2010 Nov 21;55(22):6817-6839.
38. Pichardo S, Hynynen K. New design for an endoesophageal sector-based array for the treatment of atrial fibrillation: a parametric simulation study. IEEE Trans Ultrason Ferroelectr Freq Control 2009;56(3):600-612.
39. Engel DJ, Muratore R, Hirata K, Otsuka R, Fujikura K, Sugioka K, et al. Myocardial lesion formation using high-intensity focused ultrasound. J Am Soc Echocardiogr 2006 Jul;19(7):932-937.
40. Pichardo S, Hynynen K. Circumferential lesion formation around the pulmonary veins in the left atrium with focused ultrasound using a 2D-array endoesophageal device: a numerical study. Phys Med Biol 2007 Aug 21;52(16):4923-4942.
41. Leong T, Ashokkumar M, Kentish S. The fundamentals of power ultrasound-a review. Acoustics Australia 2011;39(2-55).
42. Hill C. The Wider Context of Sonography. Physical Principles of Medical Ultrasonics, Second Edition 2004:337-347.
43. T. The acoustic bubble: Access Online via Elsevier; 1994.
44. Chavrier F, Chapelon JY, Gelet A, Cathignol D. Modeling of high-intensity focused ultrasound- induced lesions in the presence of cavitation bubbles. J Acoust Soc Am 2000 Jul;108(1):432-440.
45. Sassaroli E, Hynynen K. Forced linear oscillations of microbubbles in blood capillaries. J Acoust Soc Am 2004;115(6):3235.
46. Sokka S, Gauthier TP, Hynynen K. Theoretical and experimental validation of a dual-frequency excitation method for spatial control of cavitation. Phys Med Biol 2005;50(9):2167-2179.
47. Barnett S, ter Haar G, Ziskin M, Rott H, Duck F, Maeda K. International recommendations and guidelines for the safe use of diagnostic ultrasound in medicine. Ultrasound Med Biol 2000;26(3):355-366.
48. Aptel F, Lafon C. Therapeutic applications of ultrasound in ophthalmology. Int J Hyperthermia 2012;28(4):405-418.
49. Fry WJ, Fry FJ. Fundamental Neurological Research and Human Neurosurgery Using Intense Ultrasound. IRE Transactions on Medical Electronics 1960;ME-7:166-181.
50. Coleman DJ, Lizzi FL, Driller J, Rosado AL, Burgess SE, Torpey JH, et al. Therapeutic ultrasound in the treatment of glaucoma. II. Clinical applications. Ophthalmology 1985 Mar;92(3):347-353.
51. Tempany CM, Stewart EA, McDannold N, Quade BJ, Jolesz FA, Hynynen K. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology 2003 Mar;226(3):897-905.
52. Chopra R, Baker N, Choy V, Boyes A, Tang K, Bradwell D, et al. MRI-compatible transurethral ultrasound system for the treatment of localized prostate cancer using rotational control. Med Phys 2008 Apr;35(4):1346-1357.
53. Crouzet S, Rebillard X, Chevallier D, Rischmann P, Pasticier G, Garcia G, et al. Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients. Eur Urol 2010 Oct;58(4):559-566.
54. Gelet A, Chapelon JY, Bouvier R, Rouviere O, Lasne Y, Lyonnet D, et al. Transrectal high- intensity focused ultrasound: minimally invasive therapy of localized prostate cancer. J Endourol 2000 Aug;14(6):519-528.
55. Sanghvi NT, Foster RS, Bihrle R, Casey R, Uchida T, Phillips MH, et al. Noninvasive surgery of prostate tissue by high intensity focused ultrasound: an updated report. Eur J Ultrasound 1999 Mar;9(1):19-29.
56. Uchida T, Sanghvi NT, Gardner TA, Koch MO, Ishii D, Minei S, et al. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report. Urology 2002 Mar;59(3):394-8; discussion 398-9.
57. Huber PE, Jenne JW, Rastert R, Simiantonakis I, Sinn HP, Strittmatter HJ, et al. A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery. Cancer Res 2001 Dec 1;61(23):8441-8447.
58. Furusawa H, Namba K, Thomsen S, Akiyama F, Bendet A, Tanaka C, et al. Magnetic resonance- guided focused ultrasound surgery of breast cancer: reliability and effectiveness. J Am Coll Surg 2006 Jul;203(1):54-63.
59. Zimmer JE, Hynynen K, He DS, Marcus F. The feasibility of using ultrasound for cardiac ablation. IEEE Trans Biomed Eng 1995 Sep;42(9):891-897.
60. Orgera G, Krokidis M, Monfardini L, Bonomo G, Della Vigna P, Fazio N, et al. High intensity focused ultrasound ablation of pancreatic neuroendocrine tumours: report of two cases. Cardiovasc Intervent Radiol 2011 Apr;34(2):419-423.
61. Melodelima D, Vincenot J, Chen Y, Dupre A, Rivoire M, Chapelon JY. Thermal ablation by high-intensity-focused ultrasound using a toroidal transducer for the treatment of colorectal liver metastases during an open procedure. Clinical results J Acoust Soc Am 2013 May;133(5):3410.
62. Melodelima D, Salomir R, Chapelon JY, Theillere Y, Moonen C, Cathignol D. Intraluminal high intensity ultrasound treatment in the esophagus under fast MR temperature mapping: in vivo studies. Magn Reson Med 2005 Oct;54(4):975-982.
63. Wright C, Hynynen K, Goertz D. In vitro and in vivo high-intensity focused ultrasound thrombolysis. Invest Radiol 2012 Apr;47(4):217-225.
64. Vaezy S, Marti R, Mourad P, Crum L. Hemostasis using high intensity focused ultrasound. Eur J Ultrasound 1999 Mar;9(1):79-87.
65. Hwang JH, Zhou Y, Warren C, Brayman AA, Crum LA. Targeted venous occlusion using pulsed high-intensity focused ultrasound. IEEE Trans Biomed Eng 2010 Jan;57(1):37-40.
66. Pichardo S, Milleret R, Curiel L, Pichot O, Chapelon JY. In vitro experimental study on the treatment of superficial venous insufficiency with high-intensity focused ultrasound. Ultrasound Med Biol 2006 Jun;32(6):883-891.
67. Madersbacher S, Pedevilla M, Vingers L, Susani M, Marberger M. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 1995 Aug 1;55(15):3346-3351.
68. Niu L, Wang Z, Zou W, Zhang L, Xiang L, Zhu H, et al. Pathological changes on human breast cancer specimens ablated in vitro with high-intensity focused ultrasound. Ultrasound Med Biol 2010 Sep;36(9):1437-1444.
69. Wu F, Wang ZB, Cao YD, Zhou Q, Zhang Y, Xu ZL, et al. Expression of tumor antigens and heat- shock protein 70 in breast cancer cells after high- intensity focused ultrasound ablation. Ann Surg Oncol 2007 Mar;14(3):1237-1242.
70. Wu F, Wang ZB, Lu P, Xu ZL, Chen WZ, Zhu H, et al. Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. Ultrasound Med Biol 2004 Sep;30 (9):1217-1222.
71. Paparel P, Curiel L, Chesnais S, Ecochard R, Chapelon JY, Gelet A. Synergistic inhibitory effect of high-intensity focused ultrasound combined with chemotherapy on Dunning adenocarcinoma. BJU Int 2005 Apr;95(6):881-885.
72. Gelet A, Chapelon JY, Bouvier R, Rouviere O, Lyonnet D, Dubernard JM. Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome. Eur Urol 2001 Aug;40(2):124-129.
73. Prat F, Centarti M, Sibille A, Abou el Fadil FA, Henry L, Chapelon JY, et al. Extracorporeal high- intensity focused ultrasound for VX2 liver tumors in the rabbit. Hepatology 1995 Mar;21(3):832-836.
74. Kinsey AM, Tyreus PD, Rieke V, Butts K, Nau WH, Sommer G, et al. Interstitial ultrasound applicators with dynamic angular control for thermal ablation of tumors under MR-guidance. Conf Proc IEEE Eng Med Biol Soc 2004;4:2496-2499.
75. Chaussy C, Thuroff S, Rebillard X, Gelet A. Technology insight: High-intensity focused ultrasound for urologic cancers. Nat Clin Pract Urol 2005 Apr;2(4):191-198.
76. Gorny KR, Hangiandreou NJ, Hesley GK, Gostout BS, McGee KP, Felmlee JP. MR guided focused ultrasound: technical acceptance measures for a clinical system. Phys Med Biol 2006 Jun 21;51(12):3155-3173.
77. Harris GR. FDA regulation of clinical high intensity focused ultrasound (HIFU) devices. 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society 2009:145-148.
78. Mitragotri S. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat Rev Drug Discov 2005 Mar;4(3):255-260.
79. Escobar-Chavez JJ, Bonilla-Martinez D, Villegas- Gonzalez MA, Rodriguez-Cruz IM, Dominguez- Delgado CL. The use of sonophoresis in the administration of drugs throughout the skin. J Pharm Pharm Sci 2009;12(1):88-115.
80. Tezel A, Mitragotri S. Interactions of Inertial Cavitation Bubbles with Stratum Corneum Lipid Bilayers during Low-Frequency Sonophoresis. Biophys J 2003;85(6):3502-3512.
81. Ferrara K, Pollard R, Borden M. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 2007;9:415-447.
82. Zhou Y, Cui J, Deng CX. Dynamics of sonoporation correlated with acoustic cavitation activities. Biophys J 2008 Apr 1;94(7):L51-3.
83. Zhou Y, Kumon RE, Cui J, Deng CX. The size of sonoporation pores on the cell membrane. Ultrasound Med Biol 2009 Oct;35(10):1756-1760.
84. Meijering BD, Juffermans LJ, van Wamel A, Henning RH, Zuhorn IS, Emmer M, et al. Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ Res 2009 Mar 13;104(5):679-687.
85. Kedar RP, Cosgrove D, McCready VR, Bamber JC, Carter ER. Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress Radiology 1996 Mar;198(3):679-686.
86. Ries F, Honisch C, Lambertz M, Schlief R. A transpulmonary contrast medium enhances the transcranial. Doppler signal in humans Stroke 1993 Dec;24(12):1903-1909.
87. Wu J, Pepe J, Rincon M. Sonoporation, anti-cancer drug and antibody delivery using ultrasound. Ultrasonics 2006 Dec 22;44 Suppl 1:e21-5.
88. Mehier-Humbert S, Bettinger T, Yan F, Guy RH. Plasma membrane poration induced by ultrasound exposure: implication for drug delivery. J Control Release 2005 May 5;104(1):213-222.
89. Kinoshita M, Hynynen K. A novel method for the intracellular delivery of siRNA using microbubble- enhanced focused ultrasound. Biochem Biophys Res Commun 2005 Sep 23;335(2):393-399.
90. Kinoshita M, Hynynen K. Key factors that affect sonoporation efficiency in in vitro settings: the importance of standing wave in sonoporation. Biochem Biophys Res Commun 2007 Aug 10;359(4):860-865.
91. Kinoshita M, Hynynen K. Intracellular delivery of Bak BH3 peptide by microbubble-enhanced ultrasound. Pharm Res 2005 May;22(5):716-720.
92. Zhang CB, Cao HL, Li Q, Tu J, Guo X, Liu Z, et al. Enhancement effect of ultrasound-induced microbubble cavitation on branched polyethylenimine-mediated VEGF(165) transfection with varied N/P ratio. Ultrasound Med Biol 2013 Jan;39(1):161-171.
93. Bao S, Thrall BD, Miller DL. Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med Biol 1997;23(6):953-959.
94. Qiu Y, Zhang C, Tu J, Zhang D. Microbubble- induced sonoporation involved in ultrasound- mediated DNA transfection in vitro at low acoustic pressures. J Biomech 2012 May 11;45(8):1339-1345.
95. Pichardo S, Togtema M, Jackson R, Zehbe I, Curiel L. Influence of cell line and cell cycle phase on sonoporation transfection efficiency in cervical carcinoma cells under the same physical conditions. IEEE Trans Ultrason Ferroelectr Freq Control 2013 Feb;60(2):432-435.
96. Togtema M, Pichardo S, Jackson R, Lambert PF, Curiel L, Zehbe I. Sonoporation delivery of monoclonal antibodies against human papillomavirus 16 E6 restores p53 expression in transformed cervical keratinocytes. PLoS One 2012;7(11):e50730.
97. Ibsen S, Schutt CE, Esener S. Microbubble- mediated ultrasound therapy: a review of its potential in cancer treatment. Drug Des Devel Ther 2013 May 3;7:375-388.
98. Sakakima Y, Hayashi S, Yagi Y, Hayakawa A, Tachibana K, Nakao A. Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents. Cancer Gene Ther 2005;12(11):884-889.
99. Bekeredjian R, Chen S, Grayburn PA, Shohet RV. Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction. Ultrasound Med Biol 2005 May;31(5):687-691.
100. Tsunoda S, Mazda O, Oda Y, Iida Y, Akabame S, Kishida T, et al. Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. Biochem Biophys Res Commun 2005;336(1):118-127.
101. Liang HD. Sonoporation, drug delivery, and gene therapy. Proceedings of the Institution of Mechanical Engineers Part H Journal of Engineering in Medicine 2009;224(2):343.
102. Harrison, G H Harrison, E K Balcer Kubiczek, H A Eddy. Potentiation of Chemotherapy by Low-level Ultrasound. Int J Radiat Biol 1991;59(6):1453-1466.
103. Larkin JO, Casey GD, Tangney M, Cashman J, Collins CG, Soden DM, et al. Effective tumor treatment using optimized ultrasound-mediated delivery of bleomycin. Ultrasound Med Biol 2008 Mar;34(3):406-413.
104. Feril LB, Jr, Kondo T, Takaya K, Riesz P. Enhanced ultrasound-induced apoptosis and cell lysis by a hypotonic medium. Int J Radiat Biol 2004 Feb;80(2):165-175.
105. Ashush H, Rozenszajn LA, Blass M, Barda-Saad M, Azimov D, Radnay J, et al. Apoptosis induction of human myeloid leukemic cells by ultrasound exposure. Cancer Res 2000 Feb 15;60(4):1014-1020.
106. Zhang Z, Chen J, Chen L, Yang X, Zhong H, Qi X, et al. Low frequency and intensity ultrasound induces apoptosis of brain glioma in rats mediated by caspase-3, Bcl-2, and surviving. Brain Res 2012 Sep 14;1473:25-34.
107. Ferrante EA, Pickard JE, Rychak J, Klibanov A, Ley K. Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow. J Control Release 2009 Dec 3;140(2):100-107.
108. Guenther F, von zur Muhlen C, Ferrante EA, Grundmann S, Bode C, Klibanov AL. An ultrasound contrast agent targeted to P-selectin detects activated platelets at supra-arterial shear flow conditions. Invest Radiol 2010 Oct;45(10):586-591.
109. Pochon S, Tardy I, Bussat P, Bettinger T, Brochot J, von Wronski M, et al. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol 2010;45(2):89-95.
110. Wang L, Li L, Guo Y, Tong H, Fan X, Ding J, et al. Construction and in vitro/in vivo targeting of PSMA-targeted nanoscale microbubbles in prostate cancer. Prostate 2013 Mar 26.
111. Klibanov AL, Hughes MS, Villanueva FS, Jankowski RJ, Wagner WR, Wojdyla JK, et al. Targeting and ultrasound imaging of microbubble- based contrast agents. MAGMA 1999 Aug;8(3):177-184.
112. Karshafian R, Samac S, Bevan PD, Burns PN. Microbubble mediated sonoporation of cells in suspension: clonogenic viability and influence of molecular size on uptake. Ultrasonics 2010 Jun;50(7):691-697.
113. Karshafian R, Bevan PD, Williams R, Samac S, Burns PN. Sonoporation by ultrasound-activated microbubble contrast agents: effect of acoustic exposure parameters on cell membrane permeability and cell viability. Ultrasound Med Biol 2009 May;35(5):847-860.
114. Yudina A, Lepetit-Coiffe M, Moonen CT. Evaluation of the temporal window for drug delivery following ultrasound-mediated membrane permeability enhancement. Mol Imaging Biol 2011 Apr;13(2):239-249.
115. Treat LH, McDannold N, Vykhodtseva N, Zhang Y, Tam K, Hynynen K. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 2007 Aug 15;121(4):901-907.
116. Hynynen K. Ultrasound for drug and gene delivery to the brain. Adv Drug Deliv Rev 2008 Jun 30;60(10):1209-1217.
117. Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 2001 Sep;220(3):640-646.
118. Sheikov N, McDannold N, Vykhodtseva N, Jolesz F, Hynynen K. Cellular mechanisms of the blood- brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med Biol 2004;30(7):979-989.
119. Meairs S, Alonso A. Ultrasound, microbubbles and the blood-brain barrier. Prog Biophys Mol Biol 2007 Jan-Apr;93(1-3):354-362.
120. Hynynen K, McDannold N, Sheikov N, Jolesz F, Vykhodtseva N. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans- skull sonications. Neuroimage 2005;24(1):12-20.
121. McDannold N, Vykhodtseva N, Hynynen K. Blood-Brain Barrier Disruption Induced by Focused Ultrasound and Circulating Preformed Microbubbles Appears to Be Characterized by the Mechanical Index. Ultrasound Med Biol 2008;34(5):834-840.
122. Kinoshita M, McDannold N, Jolesz FA, Hynynen K. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Biochem Biophys Res Commun 2006 Feb 24;340(4):1085-1090.
123. Marquet F, Tung YS, Teichert T, Ferrera VP, Konofagou EE. Noninvasive, transient and selective blood-brain barrier opening in non-human primates in vivo. PLoS One 2011;6(7):e22598.
124. Aryal M, Vykhodtseva N, Zhang YZ, Park J, McDannold N. Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model. J Control Release 2013 Jul 10;169(1-2):103-111.
125. Park EJ, Zhang YZ, Vykhodtseva N, McDannold N. Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model. J Control Release 2012 Nov 10;163(3):277-284.
126. Jordão J, Ayala-Grosso C, Markham K, Huang Y, Chopra R, McLaurin J, et al. Antibodies Targeted to the Brain with Image-Guided Focused Ultrasound Reduces Amyloid-b Plaque Load in the TgCRND8 Mouse Model of Alzheimer's Disease. PLoS ONE 2010;5(5):e10549.
127. Alonso A, Reinz E, Leuchs B, Kleinschmidt J, Fatar M, Geers B, et al. Focal Delivery of AAV2/1- transgenes Into the Rat Brain by Localized Ultrasound-induced BBB Opening. Mol Ther Nucleic Acids 2013 Feb 19;2:e73.
128. Porter TR,. The utilization of ultrasound and microbubbles for therapy in acute coronary syndromes. Cardiovasc Res 2009;83(4):636-642.
129. Akiyama M, Ishibashi T, Yamada T, Furuhata H. Low-frequency ultrasound penetrates the cranium and enhances thrombolysis in vitro. Neurosurgery 1998 Oct;43(4):828-32; discussion 832-3.
130. Bor-Seng-Shu E, Nogueira Rde C, Figueiredo EG, Evaristo EF, Conforto AB, Teixeira MJ. Sonothrombolysis for acute ischemic stroke: a systematic review of randomized controlled trials. Neurosurg Focus 2012 Jan;32(1):E5.
131. Tsivgoulis G, Alexandrov AV. Ultrasound enhanced thrombolysis: applications in acute cerebral ischemia. J Clin Neurol 2007 Mar;3(1):1-8.
132. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, et al. Ultrasound- enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004 Nov 18;351(21):2170-2178.
133. Califf RM, Fortin DF, Tenaglia AN, Sane DC. Clinical risks of thrombolytic therapy. Am J Cardiol 1992 Jan 3;69(2):12A-20A.
134. Susman E. News from the International Stroke Conference: Hands-free Headband Device Improves Clotbuster Efficacy. Neurology today 2012;12(6):24.
135. Maxwell A, Cain C, Duryea A, Yuan L, Gurm H, Xu Z. Noninvasive thrombolysis using pulsed ultrasound cavitation therapy - Histotrispy. Ultrasound Med Biol 2009;35(12):1982-1994.
136. Marsh JN, Senpan A, Hu G, Scott MJ, Gaffney PJ, Wickline SA, et al. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis. Nanomedicine 2007;2(4):533-543.
137. McCarthy JR, Sazonova IY, Erdem SS, Hara T, Thompson BD, Patel P, et al. Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy. Nanomedicine (Lond) 2012 Jul;7(7):1017-1028.
138. Ta T, Porter TM. Thermosensitive liposomes for localized delivery and triggered release of chemotherapy. J Control Release 2013 Jul 10;169(1-2):112-125.
139. Yatvin MB, Weinstein JN, Dennis WH, Blumenthal R. Design of liposomes for enhanced local release of drugs by hyperthermia. Science 1978 Dec 22;202(4374):1290-1293.
140. Hynynen K, Lulu BA. Hyperthermia in cancer treatment. Invest Radiol 1990 Jul;25(7):824-834.
141. Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res 2000 Dec 15;60(24):6950-6957.
142. Needham D, Anyarambhatla G, Kong G, Dewhirst MW. A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res 2000 Mar 1;60(5):1197-1201.
143. Huang SK, Stauffer PR, Hong K, Guo JW, Phillips TL, Huang A, et al. Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res 1994 Apr 15;54(8):2186-2191.
144. Manzoor AA, Lindner LH, Landon CD, Park JY, Simnick AJ, Dreher MR, et al. Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. Cancer Res 2012 Nov 1;72(21):5566-5575.
145. Staruch R, Chopra R, Hynynen K. Localised drug release using MRI-controlled focused ultrasound hyperthermia. Int J Hyperthermia 2011;27(2):156-171.
146. Staruch R, Chopra R, Hynynen K. Hyperthermia in bone generated with MR imaging-controlled focused ultrasound: control strategies and drug delivery. Radiology 2012 Apr;263(1):117-127.
147. Ranjan A, Jacobs GC, Woods DL, Negussie AH, Partanen A, Yarmolenko PS, et al. Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model. J Control Release 2012 Mar 28;158(3):487-494.
148. de Smet M, Langereis S, van den Bosch S, Grull H. Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance. J Control Release 2010 Apr 2;143(1):120-127.
149. Negussie AH, Yarmolenko PS, Partanen A, Ranjan A, Jacobs G, Woods D, et al. Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound. Int J Hyperthermia 2011;27(2):140-155.
150. de Smet M, Heijman E, Langereis S, Hijnen NM, Grull H. Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study. J Control Release 2011 Feb 28;150(1):102-110.
151. de Smet M, Langereis S, van den Bosch S, Bitter K, Hijnen NM, Heijman E, et al. SPECT/CT imaging of temperature-sensitive liposomes for MR-image guided drug delivery with high intensity focused ultrasound. J Control Release 2013 Jul 10;169(1-2):82-90.
152. Gasselhuber A, Dreher MR, Partanen A, Yarmolenko PS, Woods D, Wood BJ, et al. Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivovalidation. Int J Hyperthermia 2012;28(4):337-348.
153. Oerlemans C, Deckers R, Storm G, Hennink WE, Nijsen JF. Evidence for a new mechanism behind HIFU-triggered release from liposomes. J Control Release 2013 Jun 28;168(3):327-333.
154. Li L, ten Hagen TL, Hossann M, Suss R, van Rhoon GC, Eggermont AM, et al. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy. J Control Release 2013 Jun 10;168(2):142-150.
155. Park SM, Kim MS, Park SJ, Park ES, Choi KS, Kim YS, et al. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high- intensity focused ultrasound (HIFU). J Control Release 2013 Sep 28;170(3):373-379.
156. Deckers R, Paradissis A, Oerlemans C, Talelli M, Storm G, Hennink WE, et al. New insights into the HIFU-triggered release from polymeric micelles. Langmuir 2013 Jul 30;29(30):9483-9490.
157. Gong J, Chen M, Zheng Y, Wang S, Wang Y. Polymeric micelles drug delivery system in oncology. J Control Release 2012 May 10;159(3):312-323.
158. Chapelon JY, Ribault M, Vernier F, Souchon R, Gelet A. Treatment of localised prostate cancer with transrectal high intensity focused ultrasound. Eur J Ultrasound 1999 Mar;9(1):31-38.
159. Yagel S. High-intensity focused ultrasound: a revolution in non-invasive ultrasound treatment? Ultrasound Obstet Gynecol 2004 Mar;23(3):216-217.
160. Chapelon JY, Margonari J, Bouvier R, Cathignol D, Gorry F, Gelet A. Tissue ablation by focused ultrasound. Prog Urol 1991 Apr;1(2):231-243.
161. Hynynen K, Darkazanli A, Unger E, Schenck JF. MRI-guided noninvasive ultrasound surgery. Med Phys 1993 Jan-Feb;20(1):107-115.
162. Chung AH, Jolesz FA, Hynynen K. Thermal dosimetry of a focused ultrasound beam in vivo by magnetic resonance imaging. Med Phys 1999 Sep;26(9):2017-2026.
163. Quesson B, de Zwart JA, Moonen CT. Magnetic resonance temperature imaging for guidance of thermotherapy. J Magn Reson Imaging 2000 Oct;12(4):525-533.
164. McDannold NJ, King RL, Jolesz FA, Hynynen KH. Usefulness of MR imaging-derived thermometry and dosimetry in determining the threshold for tissue damage induced by thermal surgery in rabbits. Radiology 2000 Aug;216(2):517-523.
165. Blana A, Rogenhofer S, Ganzer R, Lunz JC, Schostak M, Wieland WF, et al. Eight Years' Experience With High-Intensity Focused Ultrasonography for Treatment of Localized Prostate Cancer. Urology 2008 Sep 29;72(6):1329-1333.
166. Uchida T, Ohkusa H, Yamashita H, Shoji S, Nagata Y, Hyodo T, et al. Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. Int J Urol 2006 Mar;13(3):228-233.
167. Dorenberg EJ, Courivaud F, Ring E, Hald K, Jakobsen JA, Fosse E, et al. Volumetric ablation of uterine fibroids using Sonalleve high-intensity focused ultrasound in a 3 Tesla scanner - first clinical assessment Minim Invasive. Ther Allied Technol 2012 Jul 16.
168. Hesley GK, Gorny KR, Woodrum DA. MR-Guided Focused Ultrasound for the Treatment of Uterine Fibroids Cardiovasc. Intervent Radiol 2012 Mar 28.
169. Kim HS, Baik JH, Pham LD, Jacobs MA. MR- guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes. Acad Radiol 2011 Aug;18(8):970-976.
170. Rabinovici J, Inbar Y, Revel A, Zalel Y, Gomori JM, Itzchak Y, et al. Clinical improvement and shrinkage of uterine fibroids after thermal ablation by magnetic resonance-guided focused ultrasound surgery. Ultrasound Obstet Gynecol 2007 Oct;30(5):771-777.
171. Huisman M, van den Bosch MA. MR-guided high- intensity focused ultrasound for noninvasive cancer treatment. Cancer Imaging 2011 Oct 3;11:S161-6.
172. Gianfelice D, Gupta C, Kucharczyk W, Bret P, Havill D, Clemons M. Palliative treatment of painful bone metastases with MR imaging--guided focused ultrasound. Radiology 2008 Oct;249(1):355-363.
173. Catane R, Beck A, Inbar Y, Rabin T, Shabshin N, Hengst S, et al. MR-guided focused ultrasound surgery (MRgFUS) for the palliation of pain in patients with bone metastases--preliminary clinical experience. Ann Oncol 2007 Jan;18(1):163-167.
174. Lawrentschuk N, Finelli A, Van der Kwast TH, Ryan P, Bolton DM, Fleshner NE, et al. Salvage radical prostatectomy following primary high intensity focused ultrasound for treatment of prostate cancer. J Urol 2011 Mar;185(3):862-868.
175. Lindner U, Trachtenberg J, Lawrentschuk N. Focal therapy in prostate cancer: modalities, findings and future considerations. Nat Rev Urol 2010 Oct;7(10):562-571.
176. Curiel L, Souchon R, Rouviere O, Gelet A, Chapelon JY. Elastography for the follow-up of high-intensity focused ultrasound prostate cancer treatment: initial comparison with MRI. Ultrasound Med Biol 2005 Nov;31(11):1461-1468.
177. Souchon R, Rouviere O, Gelet A, Detti V, Srinivasan S, Ophir J, et al. Visualisation of HIFU lesions using elastography of the human prostate in vivo: preliminary results. Ultrasound Med Biol 2003 Jul;29(7):1007-1015.
178. Curiel L, Chopra R, Hynynen K. In vivo monitoring of Focused Ultrasound Surgery using Local Harmonic Motion. Ultrasound Med Biol 2009;35(1):65-78.
179. Tan M, Burden-Gulley SM, Li W, Wu X, Lindner D, Brady-Kalnay SM, et al. MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model. Pharm Res 2012 Apr;29(4):953-960.
180. Gohr-Rosenthal S, Schmitt-Willich H, Ebert W, Conrad J. The demonstration of human tumors on nude mice using gadolinium-labelled monoclonal antibodies for magnetic resonance imaging. Invest Radiol 1993 Sep;28(9):789-795.
181. Artemov D, Mori N, Okollie B, Bhujwalla ZM. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn Reson Med 2003 Mar;49(3):403-408.
182. Tomanek B, Iqbal U, Blasiak B, Abulrob A, Albaghdadi H, Matyas JR, et al. Evaluation of brain tumor vessels specific contrast agents for glioblastoma imaging. Neuro Oncol 2012 Jan;14(1):53-63.
183. Bachawal SV, Jensen KC, Lutz AM, Gambhir SS, Tranquart F, Tian L, et al. Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model. Cancer Res 2013 Mar 15;73(6):1689-1698.
184. Li T, Tachibana K, Kuroki M, Kuroki M. Gene Transfer with Echo-enhanced Contrast Agents: Comparison between Albunex, Optison, and Levovist in Mice--Initial Results. Radiology 2003;229(2):423-428.
185. Forbes MM, Steinberg RL, O'Brien WD, Jr. Examination of inertial cavitation of Optison in producing sonoporation of chinese hamster ovary cells. Ultrasound Med Biol 2008 Dec;34(12):2009-2018.
186. Liu F, Zhu J, Huang Y, Guo W, Rui M, Xu Y, et al. Contrast imaging and gene delivery through the combined use of novel cationic liposomal microbubbles and ultrasound in rat carotid arteries. Arch Med Sci 2013 Apr 20;9(2):347-353.